Lasa Supergenerics (India) Today
| LASA Stock | 26.58 1.26 4.53% |
Performance0 of 100
| Odds Of DistressLess than 37
|
Lasa Supergenerics is selling for under 26.58 as of the 11th of December 2024; that is 4.53 percent decrease since the beginning of the trading day. The stock's lowest day price was 26.58. Lasa Supergenerics has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 12th of September 2024 and ending today, the 11th of December 2024. Click here to learn more.
Moving together with Lasa Stock
Moving against Lasa Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lasa Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lasa Supergenerics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lasa Supergenerics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman MD | Omkar Herlekar |
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Lasa Supergenerics Limited (LASA) is traded on National Stock Exchange of India in India and employs 77 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.33 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lasa Supergenerics's market, we take the total number of its shares issued and multiply it by Lasa Supergenerics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lasa Supergenerics operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 50.1 M outstanding shares.
Lasa Supergenerics Limited has accumulated about 15.91 M in cash with 21.38 M of positive cash flow from operations.
Check Lasa Supergenerics Probability Of Bankruptcy
Ownership AllocationLasa Supergenerics maintains a total of 50.1 Million outstanding shares. Lasa Supergenerics Limited secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 62.7 % of Lasa Supergenerics Limited outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lasa Ownership Details
Lasa Supergenerics Risk Profiles
Although Lasa Supergenerics' alpha and beta are two of the key measurements used to evaluate Lasa Supergenerics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.19 | |||
| Standard Deviation | 2.67 | |||
| Variance | 7.14 | |||
| Risk Adjusted Performance | (0.03) |
Lasa Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lasa Supergenerics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Lasa Supergenerics Corporate Management
Elected by the shareholders, the Lasa Supergenerics' board of directors comprises two types of representatives: Lasa Supergenerics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lasa. The board's role is to monitor Lasa Supergenerics' management team and ensure that shareholders' interests are well served. Lasa Supergenerics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lasa Supergenerics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Varsha Joshi | Chief Officer | Profile | |
| Anil Fargade | Accounts Officer | Profile | |
| Ankita Shetty | Company Officer | Profile | |
| Sunil Sitale | Manager Admin | Profile | |
| Mitti Jain | Company Officer | Profile |
Additional Tools for Lasa Stock Analysis
When running Lasa Supergenerics' price analysis, check to measure Lasa Supergenerics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lasa Supergenerics is operating at the current time. Most of Lasa Supergenerics' value examination focuses on studying past and present price action to predict the probability of Lasa Supergenerics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lasa Supergenerics' price. Additionally, you may evaluate how the addition of Lasa Supergenerics to your portfolios can decrease your overall portfolio volatility.